General
Preferred name
GINSENOSIDE RB1
Synonyms
Gypenoside Ⅲ ()
Gypenoside III ()
Gypenoside ¢ó ()
P&D ID
PD012060
CAS
41753-43-9
Tags
available
drug candidate
Drug Status
nutraceutical
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Ginsenoside Rb1, a main constituent of the root of Panax ginseng, inhibits Na+, K+-ATPase activity with an IC50 of 6.3¡À1.0 ¦ÌM. Ginsenoside also inhibits IRAK-1 activation and phosphorylation of NF-¦ÊB p65 .
DESCRIPTION Ginsenoside Rb1 (Gypenoside Ⅲ) is part of a class of steroid glycosides; may have properties that inhibit or prevent the growth of tumors. (TargetMol Bioactive Compound Library)
Compound Sets
5
Cayman Chemical Bioactives
DrugBank
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
26
Properties
(calculated by RDKit )
Molecular Weight
1108.6
Hydrogen Bond Acceptors
23
Hydrogen Bond Donors
15
Rotatable Bonds
16
Ring Count
8
Aromatic Ring Count
0
cLogP
-2.2
TPSA
377.29
Fraction CSP3
0.96
Chiral centers
30.0
Largest ring
6.0
QED
0.06
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Autophagy
Immunology/Inflammation
Membrane Transporter/Ion Channel
Microbiology/virology
NF-κB
Anti-infection
Vitamin D Related/Nuclear Receptor
NF-¦ÊB
Target
HSV
IRAK
Mitophagy
Na+/K+ ATPase
Pregnane X Receptor (PXR)
ATPase,IFN,IRAK,NF-¦ÊB,NOS,TLR,TNF-alpha
Na+/K+-ATPase
Source data